• Education
  • Points
  •  Download App
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates

Other Services
 Education
 Points
  Download App
Country
hong kong
malaysia
indonesia
thailand
philippines
vietnam
india
australia
korea
new zealand
Account
The MIMS logo.
  1. Medical News & Updates
  2. ...
    • Medical News & Updates
  3. List of News & Updates

News & Updates

A red magnifying glass.
Search
Filter by Specialty:
CardiologyMultidisciplinaryDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
CardiologyMultidisciplinaryDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy

Filters

Specialty:
CardiologyMultidisciplinaryDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
Show Multimedia Only
Admissions for acute myocardial infarction with rheumatoid arthritis on the rise
Admissions for acute myocardial infarction with rheumatoid arthritis on the rise
07 Oct 2020

While hospitalizations are on the rise for acute myocardial infarction (AMI) patients with rheumatoid arthritis, rates of in-hospital mortality seem to be decreasing, a new study has found.

Admissions for acute myocardial infarction with rheumatoid arthritis on the rise
07 Oct 2020
Sacubitril/valsartan cost-effective for HFREF patients
Sacubitril/valsartan cost-effective for HFREF patients
04 Oct 2020

Switching to sacubitril/valsartan is a cost-effective treatment option for patients with heart failure with reduced ejection fraction (HFREF), a recent Australia study has found.

Sacubitril/valsartan cost-effective for HFREF patients
04 Oct 2020
  • 238
The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Points
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty uat/Incremental-2.1_1828.1
Copyright © 2025 MIMS Pte Ltd. All rights reserved. UAT
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.